On May, 2 The EPS for LivaNova PLC (LIVN) Expected At $0.52

April 20, 2018 - By Damon Whitfield

LivaNova PLC (NASDAQ:LIVN) Corporate Logo

On May, 2 before the open. Investors wait LivaNova PLC (NASDAQ:LIVN) to reveal its quarterly earnings, as reported by RTT. This year’s earnings per share analyst estimate is anticipated to be $0.52. That is 26.76 % down compareed to $0.71 earnings per share for last year. If $0.52 is reported, LIVN’s profit will reach $25.11M for 42.37 P/E. Last quarter $0.88 earnings per share was reported. Analysts predicts -40.91 % negative EPS growth this quarter. LIVN hit $88.13 during the last trading session after $0.88 change.LivaNova PLC has volume of 123,988 shares. Since April 20, 2017 LIVN has risen 66.28% and is uptrending. LIVN outperformed by 54.73% the S&P 500.

LivaNova PLC, a medical device company, designs, develops, makes, and sells therapeutic solutions worldwide.The company has $4.26 billion market cap. It operates in three businesses: Neuromodulation, Cardiac Surgery, and Cardiac Rhythm Management.Last it reported negative earnings. The Neuromodulation business designs, develops, and markets its Vagus Nerve Stimulation Therapy System, an implantable device to treat drug-resistant epilepsy and treatment-resistant depression (TRD).

LivaNova PLC (NASDAQ:LIVN) Analyst Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: